– Claudio Soto, CSO & CoFounder
At Amprion, we believe successful navigation of personal brain health is the new frontier in medical science—one that brings significant, positive impact in a fast growing aging world population. Our philosophy: Prevention is the secret to health and wellness. The key lies in accurate, early detection. For the first time in history, Amprion’s revolutionary discovery technology enables individuals to track all three known biomarkers associated with Alzheimer’s and Parkinson’s, as well as how they evolve as the brain ages.
Our goal is to empower people with personal biometrics and collective knowledge that can help you and your doctor make informed choices for preventive brain care. We believe the combined brainpower of WE, the Internet, and our breakthrough discoveries will accelerate research and development of new approaches to quality of brain aging.
Learn more about the three biomarkers that are known so far to cause neurodegenerative diseases. Stay connected.
– Russ Lebovitz, CEO & CoFounder
Join the Fight
Sign up for our newsletter to stay ahead of the curve on the latest and testing availability.
Join the fight to end Alzheimer’s and Parkinson’s.
Join the Fight
Sign up for our newsletter to stay ahead of the curve on the latest and testing availability.
Join the fight to end Alzheimer’s and Parkinson’s.
AMPRION is a registered trademark of & © 2020 Amprion Inc. All Rights Reserved. | Privacy Policy
AMPRION is a registered trademark of & © 2020 Amprion Inc. All Rights Reserved. | Privacy Policy